Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 174.50
-4.00 (-2.24%)
Oct 7, 2025, 9:45 AM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 276.86 billion as of October 6, 2025. Its market cap has increased by 217.22% in one year.
Market Cap
276.86B
Enterprise Value
267.46B
Revenue
44.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
174.50
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 276.86B, an increase of 3,378.79%. That is a compound annual growth rate of 259.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 276.86B | 193.39% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 206.74B |
| Bora Pharmaceuticals Co., LTD. | 85.39B |
| Lotus Pharmaceutical | 69.95B |
| Lumosa Therapeutics | 49.53B |
| Oneness Biotech | 31.18B |
| Polaris Group | 27.66B |
| Center Laboratories | 26.65B |
| Pegavision | 24.73B |